KMT2A-CBL rearrangements in acute leukemias: clinical characteristics and genetic breakpoints

Blood Adv. 2021 Dec 28;5(24):5617-5620. doi: 10.1182/bloodadvances.2021005736.
No abstract available

MeSH terms

  • Histone-Lysine N-Methyltransferase / genetics
  • Humans
  • Leukemia*
  • Myeloid-Lymphoid Leukemia Protein* / genetics

Substances

  • Myeloid-Lymphoid Leukemia Protein
  • Histone-Lysine N-Methyltransferase